CymitQuimica logo

CAS 571190-30-2

:

Palbociclib

Description:
Palbociclib is an oral medication classified as a selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6), primarily used in the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. Its chemical formula is C24H29N5O2, and it features a complex structure that includes a pyridazine ring, which is crucial for its biological activity. Palbociclib works by disrupting the cell cycle, specifically inhibiting the transition from the G1 phase to the S phase, thereby preventing cancer cell proliferation. The substance is typically administered in combination with aromatase inhibitors or estrogen receptor antagonists to enhance therapeutic efficacy. Palbociclib is characterized by its moderate solubility in organic solvents and relatively low solubility in water, which can influence its bioavailability. Its pharmacokinetics indicate a significant first-pass metabolism, primarily by the liver, and it has a half-life that supports once-daily dosing. As with many targeted therapies, monitoring for side effects such as neutropenia is essential during treatment.
Formula:C24H29N7O2
InChI:InChI=1S/C24H29N7O2/c1-15-19-14-27-24(28-20-8-7-18(13-26-20)30-11-9-25-10-12-30)29-22(19)31(17-5-3-4-6-17)23(33)21(15)16(2)32/h7-8,13-14,17,25H,3-6,9-12H2,1-2H3,(H,26,27,28,29)
InChI key:InChIKey=AHJRHEGDXFFMBM-UHFFFAOYSA-N
SMILES:O=C1N(C=2C(C(C)=C1C(C)=O)=CN=C(NC3=CC=C(C=N3)N4CCNCC4)N2)C5CCCC5
Synonyms:
  • 6-Acetyl-8-cyclopentyl-5-methyl-2-((5-(1-piperazinyl)-2-pyridinyl)amino)pyrido[2,3-d]pyridin-7(8H)-one
  • 6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one
  • 6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(piperazin-1-yl)pyridin-2-yl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one
  • 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-ylpyridin-2-ylamino)-8H-pyrido(2,3-d)pyrimidin-7-one
  • Ibrance
  • Otava-Bb 1115529
  • Palbociclib
  • Palbociclib base
  • Palbocyclib
  • Pd 332991
  • See more synonyms
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 16 products.
  • Palbociclib

    CAS:
    Palbociclib
    Purity:≥98%
    Molecular weight:447.53g/mol

    Ref: 54-BUP14421

    1mg
    51.00€
    5mg
    76.00€
    10mg
    104.00€
  • Palbociclib

    CAS:
    Formula:C24H29N7O2
    Color and Shape:Yellow Solid
    Molecular weight:447.54

    Ref: 4Z-P-196001

    5mg
    To inquire
    10mg
    444.00€
    25mg
    635.00€
    50mg
    825.00€
    100mg
    To inquire
  • Palbociclib

    CAS:
    Formula:C24H29N7O2
    Purity:>97.0%(T)(HPLC)
    Color and Shape:White to Yellow to Yellow green powder to crystal
    Molecular weight:447.54

    Ref: 3B-P3315

    1g
    To inquire
    200mg
    73.00€
  • Palbociclib

    CAS:
    Color and Shape:Neat

    Ref: 86-MM3729.00

    250mg
    2,214.00€
  • Palbociclib

    CAS:
    Formula:C24H29N7O2
    Purity:(TLC) ≥ 98.0%
    Color and Shape:Yellow powder
    Molecular weight:447.53

    Ref: 7W-GX0330

    5mg
    148.00€
    25mg
    490.00€
  • Palbociclib

    CAS:
    <p>Palbociclib is an oral CDK4/6 inhibitor, halts Rb phosphorylation, arrests cell cycle, and curbs tumor growth.</p>
    Formula:C24H29N7O2
    Purity:98% - 99.9%
    Color and Shape:Solid
    Molecular weight:447.53
  • Palbociclib Sulfate Sodium Salt

    Controlled Product
    CAS:
    <p>Applications Palbociclib Sulfate is a derivative of Palbociclib (P139900) which is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.<br>References Finn, R., et al.: Breast Cancer Res., 11, 5 (2009)<br></p>
    Formula:C24H28N7NaO5S
    Color and Shape:Neat
    Molecular weight:549.58

    Ref: TR-P139905

    10mg
    236.00€
    100mg
    1,572.00€
  • Palbociclib-d4

    Controlled Product
    CAS:
    <p>Applications Palbociclib-d4 is an isotope labelled compound of Palbociclib (P139900). Palbociclib (P139900) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.<br>References Finn, R., et al.: Breast Cancer Res., 11, 5 (2009)<br></p>
    Formula:C24H25D4N7O2
    Color and Shape:Light Yellow
    Molecular weight:451.56

    Ref: TR-P139901

    1mg
    427.00€
    10mg
    2,917.00€
  • Palbociclib - Bio-X ™

    CAS:
    <p>This product is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&amp;D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.</p>
    Formula:C24H29N7O2
    Purity:Min. 95%
    Color and Shape:Powder
    Molecular weight:447.53 g/mol

    Ref: 3D-BP166224

    1mg
    135.00€
  • Palbociclib

    CAS:
    <p>Selective and potent inhibitor of cyclin-dependent kinases CDK4 and CDK6. It blocks cell cycle progression from phase G1 into S by inhibiting CDK4/6-dependent retinoblastoma (RB) phosphorylation. It has been used for the treatment of HER2 negative, estrogen receptor (ER) positive metastatic breast cancer.</p>
    Formula:C24H29N7O2
    Purity:Min. 95%
    Color and Shape:Powder
    Molecular weight:447.53 g/mol

    Ref: 3D-FA65120

    1g
    233.00€
    2g
    341.00€
    5g
    486.00€
    10g
    748.00€
    25g
    1,085.00€
  • Palbociclib-d4 Hydrochloride

    Controlled Product
    CAS:
    <p>Applications Palbociclib-d4 Hydrochloride is an intermediate in synthesizing Palbociclib-d4 (P139901), an isotope labelled compound of Palbociclib (P139900). Palbociclib (P139900) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.<br>References Finn, R., et al.: Breast Cancer Res., 11, 5 (2009)<br></p>
    Formula:C25H27D4N7O2·HCl
    Color and Shape:Neat
    Molecular weight:465.58 + (36.46)

    Ref: TR-P139937

    5mg
    845.00€
    10mg
    1,475.00€
    2500µg
    461.00€
  • Palbociclib N-β-D-Glucuronide Sodium Salt (Technical Grade, ~65%)

    Controlled Product
    CAS:
    <p>Applications Palbociclib N-β-D-Glucuronide is a derivative of Palbociclib (P139900) which is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.<br>References Finn, R., et al.: Breast Cancer Res., 11, 5 (2009)<br></p>
    Formula:C30H36N7NaO8
    Purity:~65%
    Color and Shape:Neat
    Molecular weight:645.64

    Ref: TR-P139910

    1mg
    451.00€
    5mg
    1,618.00€
    10mg
    2,995.00€
  • Palbociclib

    CAS:
    Purity:95%
    Color and Shape:Solid
    Molecular weight:447.5429993

    Ref: 10-F794410

    1g
    146.00€
    5g
    546.00€
  • Palbociclib

    CAS:
    <p>Applications Palbociclib (also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.<br>References Finn, R., et al.: Breast Cancer Res., 11, 5 (2009);<br></p>
    Formula:C24H29N7O2
    Color and Shape:Neat
    Molecular weight:447.53

    Ref: TR-P139900

    50mg
    131.00€
    100mg
    182.00€
    250mg
    351.00€
  • Maillard Product

    Controlled Product
    CAS:
    Formula:C36H49N7O12
    Color and Shape:Neat
    Molecular weight:771.814

    Ref: TR-M411860

    25mg
    2,058.00€